The use of aesthetic medicine in the treatment of rosacea
DOI:
https://doi.org/10.12775/QS.2024.21.54278Keywords
Botulinum toxin, rosacea, erythema, laser therapyAbstract
Introduction and purpose:
Rosacea is a chronic inflammatory dermatosis. It mainly affects the central parts of the face and manifests itself with redness, erythema, telangiectasia, and papulopustular lesions. The aim of the work is to review current rosacea therapy techniques, detailing aesthetic medicine treatments.
Material and methods:
In order to create the review, the PubMed and Scopus databases were searched in April and May 2024. The searches took place between April 24 and May 15, 2024 and consisted of a critical analysis of the acquired sources of knowledge.
State of knowledge:
The introduction of lasers to the market has revolutionized the therapy of rosacea and appropriately selected parameters and patient qualification for the treatment ensure therapeutic success. Botulinum toxin is a potent neurotoxin that blocks the release of acetylcholine from the presynaptic vesicle. Appropriate home care is an extremely important factor in maintaining the disease in the remission phase.
Conclusion
Among the possibilities of aesthetic medicine, rosacea therapy is definitely dominated by laser therapy. There are several lasers available on the market today, the most commonly used of which is IPL. Ablative lasers are used to treat a deformed nose caused by rhinophyma. Botulinum toxin is administered as an intradermal injection, thanks to which it reduces erythema and redness of the skin. After appropriate treatment by a dermatologist and aesthetic medicine doctor, well-selected home care plays a key role in maintaining the disease in the remission phase.
References
Patel, Nikunj V; Gupta, Nidhi; Shetty, Rohit. Preferred practice patterns and review on rosacea. Indian Journal of Ophthalmology 71(4):p 1382-1390, April 2023.
doi: https://doi.org/10.4103/IJO.IJO_2983_22
Sharma A, Kroumpouzos G, Kassir M, Galadari H, Goren A, Grabbe S, Goldust M. Rosacea management: A comprehensive review.
First published: 01 February 2022
doi: https://doi.org/10.1111/jocd.14816
Kang C, Shah M, Tan J. Rosacea: An Update in Diagnosis, Classification and Management By STL Volume 26 Number 4 -August 1, 2021
Narbutt J, Skibińska M. Nowoczesne leczenie ogólne w dermatologii cz.2
PZWL Warszawa 2020 page 51-60
Searle T, Al-Niaimi F, R Ali F. Rosacea
First published: 21 February 2021
https://doi.org/10.12968/hmed.2020.0417
Buddenkotte J , Martin Steinhoff M. Recent advances in understanding and managing rosacea 2018 Dec 3:7:F1000 Faculty Rev-1885
doi: https://doi.org/10.12688/f1000research.16537.1
Rudnicka L, Olszewska M, RakowskaA, Sar-Pomian M.
Współczesna dermatologia 2 PZWL Warszawa 2022 page 29
Dopytalska K, Lipa K, Sobolewski P. Artykuł przeglądowy. Znaczenie Demodex folliculorum w dermatologii.
Dermatol Rev/Przegl Dermatol 2019, 106, 507-514 doi: https://doi.org/10.5114/dr.2019.89998
Yuan X, Yin D. Association between rosacea and smoking: A systematic review and meta-analysis. Dermatol Ther2021 Mar;34(2):e14747.
doi: https://doi.org/10.1111/dth.14747
Zuuren E, Arents B, Linden M, Vermeulen S, Fedorowicz Z. Rosacea: New Concepts in Classification and Treatment. Am J Clin Dermatol. 2021; 22(4): 457–465. Published online 2021 Mar 23.
doi: https://doi.org/10.1007/s40257-021-00595-7
Linares-Espinós E, Hernández V , Domínguez-Escrig J , Fernández-Pello S, Hevia V.
Methodology of a systematic review. Actas Urol Esp (Engl EdP 2018 Oct;42) Epub 2018 May 3
doi: https://doi.org/10.1016/j.acuro.2018.01.010
Kwiek B, Walecka I, Kaszuba A, Borzęcki A. Artykuł specjalny Zastosowanie laserów w dermatologii. Rekomendacje Polskiego Towarzystwa Dermatologicznego. Część II. Leczenie zmian naczyniowych.Dermatol Rev/Przegl Dermatol 2022, 109, 165-184.
First published: 21 October 2022
WoźniackaA, Czuwara J, Krasowska D, Chlebus E. Trądzik różowaty. Rekomendacje diagnostyczno-terapeutyczne ekspertów Polskiego Towarzystwa Dermatologicznego. Część 1. Epidemiologia, klasyfikacja i obraz kliniczny Dermatol Rev/Przegl Dermatol 2022, 109, 101-121.
First published: 8 July 2022
doi: https://doi.org/10.5114/dr.2022.117981
Forbat E, Al-Niaimi F. Nonvascular uses of pulsed dye laser in clinical dermatology
Epub 2019.
First published: 19 April 2019
doi: https://doi.org/10.1111/jocd.12924
Geng R, N Bourkas A, Sibbald G. Rosacea: Clinical Aspects and Treatments. Adv Skin Wound Care 2023 Dec 1;36(12):626-634.
doi: https://doi.org/10.1097/ASW.0000000000000065.
Paasch U, Zidane M, Baron J. S2k guideline: Laser therapy of the skin
First published: 13 September 2022
doi: https://doi.org/10.1111/ddg.14879
Tüzün Y, Wolf R, Kutlubay Z, Rosacea and rhinophyma. Clinics in Dermatology
Volume 32, Issue 1, January–February 2014, Pages 35-46
doi: https://doi.org/10.1016/j.clindermatol.2013.05.024
Bennardo L, Patruno C, Zappia E. Combination of Specific Vascular Lasers and Vascular Intense Pulsed Light Improves Facial Telangiectasias and Redness
Medicina 2022, 58(5), 651.
First published: 13 July 2022
doi: https://doi.org/10.3390/medicina58050651
He G , Yang Q, Wu J, Huang Y. Treating rosacea with botulism toxin: Protocol for a systematic review and meta-analysis.
First published: 21 August 2023 https://doi.org/10.1111/jocd.15962
Eun Choi J, Werbel T, Wang Z. Botulinum toxin blocks mast cells and prevents rosacea like inflammation. Dermatol Sci. 2019 Jan(1):58-64 doi: https://doi.org/10.1016/j.jdermsci.2018.12.004
Nowicka D, Skincare in Rosacea from the Cosmetologist’s Perspective: A Narrative Review J. Clin. Med. 2023, 12(1), 115
First published: 23 December 2022
Woźniacka A, Czuwara J, Krasowska D, Chlebus E. Trądzik różowaty – rekomendacje diagnostyczno-terapeutyczne Polskiego Towarzystwa Dermatologicznego. Część 2. Leczenie.
Dermatol Rev/Przegląd Dermatol 2022, 109, 397-416.
First published: 21 April 2022
doi: https://doi.org/10.5114/dr.2022.126600
Baldwin H, Alexis A. Evidence of Barrier Deficiency in Rosacea and the Importance of Integrating OTC Skincare Products into Treatment Regimens, Published online March 16
Buddenkotte J. Recent advances in understanding and managing rosacea
First published online: 2018 Dec 3.
doi: https://doi.org/10.12688/f1000research.16537.1
Zalewska-Janowska A, Błaszczyk H. Dermatologia w gabinecie lekarza Podstawowej Opieki Zdrowotnej PZWL Warszawa 2023 page 202-207
S. Q. Geng R, N. Bourkas A, Mufti A. Rosacea: Pathogenesis and Therapeutic Correlates J Cutan Med Surg. 2024 Mar-Apr; 28(2): 178–189.
doi: https://doi.org/10.1177/12034754241229365
Thiboutot D, Anderson R, Cook-Bolden F, Draelos Z, L Gallo R, D Granstein G, Macsai M, Stein Gold L, Tan J. Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee J Am Acad Dermatol 2020 Jun;82(6):1501-1510.
https://doi.org/doi: 10.1016/j.jaad.2020.01.077.
Reszke R, Szepietowski J. Artykuł przeglądowy. Kwas azelainowy w lecznictwie dermatologicznym w świetle aktualnego stanu wiedzy.
Przegl Dermatol 2016, 103, 337–343
doi: https://doi.org/10.5114/dr.2016.61785
Placek W, Wolska H. Artykuł przeglądowy. Trądzik różowaty – aktualne poglądy na etiopatogenezę i leczenie. Przegl Dermatol 2016, 103, 387–399
doi: https://doi.org/10.5114/dr.2016.62891
W Marson J, E Baldwin H. Rosacea: a wholistic review and update from pathogenesis to diagnosis and therapy. Int J Dermatol2020 Jun;59(6):e175-e182.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Aleksandra Latała, Marcin Wąs, Natalia Zozula, Zuzanna Tomczewska, Aleksandra Rykucka, Justyna Kiełbasa, Agata Kowalczyk, Katarzyna Bil, Iga Ślesicka, Magda Przestrzelska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 1401
Number of citations: 0
